{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:35:29Z","timestamp":1785886529323,"version":"3.56.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04162-6","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:36:54Z","timestamp":1744141014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Beyond skin deep: exploring the complex molecular mechanisms and holistic management strategies of vitiligo"],"prefix":"10.1007","volume":"317","author":[{"given":"Beena Briget","family":"Kuriakose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"2","key":"4162_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/jdds.jdds_26_19","volume":"24","author":"S Almutairi","year":"2020","unstructured":"Almutairi S, Aljasser M (2020) Does psychological stress trigger or exacerbate vitiligo: more data are needed. J Dermatol Dermatol Surg 24(2):81","journal-title":"J Dermatol Dermatol Surg"},{"issue":"2","key":"4162_CR2","first-page":"167","volume":"5","author":"HA Al-Shobaili","year":"2011","unstructured":"Al-Shobaili HA (2011) Update on the genetics characterization of vitiligo. Int J Health Sci (Qassim) 5(2):167","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"4162_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/cosmetics10030084","volume":"10","author":"K Al-Smadi","year":"2023","unstructured":"Al-Smadi K, Imran M, Leite-Silva VR, Mohammed Y (2023) Vitiligo: a review of aetiology, pathogenesis, treatment, and psychosocial impact. Cosmetics 10(1):84","journal-title":"Cosmetics"},{"key":"4162_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00296","volume":"8","author":"E Baldini","year":"2017","unstructured":"Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G et al (2017) Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne) 8:296487. https:\/\/doi.org\/10.3389\/fendo.2017.00296","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4162_CR5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236(6):571\u2013592","journal-title":"Dermatology"},{"issue":"10","key":"4162_CR6","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/jdv.18257","volume":"36","author":"K Bibeau","year":"2022","unstructured":"Bibeau K, Pandya AG, Ezzedine K et al (2022) Vitiligo prevalence and quality of life among adults in Europe, Japan, and the USA. J Eur Acad Dermatol Venereol 36(10):1831","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4162_CR7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613056","volume":"12","author":"K Boniface","year":"2021","unstructured":"Boniface K, Passeron T, Seneschal J, Tulic MK (2021) Targeting innate immunity to combat cutaneous stress: the vitiligo perspective. Front Immunol 12:613056","journal-title":"Front Immunol"},{"key":"4162_CR8","doi-asserted-by":"publisher","unstructured":"Bzioueche H, Sj\u00f6din KS, West CE et al (2020) Deep skin dysbiosis in vitiligo patients: link with mitochondrial and immune changes. medRxiv. https:\/\/doi.org\/10.1101\/2020.07.29.20163469v1","DOI":"10.1101\/2020.07.29.20163469v1"},{"issue":"5","key":"4162_CR9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/a-1855-1839","volume":"89","author":"E Castillo","year":"2023","unstructured":"Castillo E, Gonz\u00e1lez-Rosende ME, Mart\u00ednez-Sol\u00eds I (2023) The use of herbal medicine in the treatment of vitiligo: an updated review. Planta Med 89(5):468\u2013483","journal-title":"Planta Med"},{"issue":"4","key":"4162_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen J, Li S, Li C (2021) Mechanisms of melanocyte death in vitiligo. Med Res Rev 41(4):1138\u20131166","journal-title":"Med Res Rev"},{"key":"4162_CR11","volume":"11","author":"L Cheng","year":"2020","unstructured":"Cheng L, Liang B, Tang XF et al (2020) Validation of susceptibility loci for vitiligo identified by GWAS in the Chinese Han population. Front Genet 11:542275","journal-title":"Front Genet"},{"issue":"8","key":"4162_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/1346-8138.13846","volume":"44","author":"CW Choi","year":"2017","unstructured":"Choi CW, Eun SH, Choi KH, Bae JM (2017) Increased risk of comorbid rheumatic disorders in vitiligo patients: a nationwide population-based study. J Dermatol 44(8):909\u2013913. https:\/\/doi.org\/10.1111\/1346-8138.13846","journal-title":"J Dermatol"},{"issue":"1","key":"4162_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13961-5","volume":"7","author":"ML Dell\u2019Anna","year":"2017","unstructured":"Dell\u2019Anna ML, Ottaviani M, Kovacs D et al (2017) Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin. Sci Rep 7(1):1\u201310","journal-title":"Sci Rep"},{"issue":"3","key":"4162_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jid.2019.08.435","volume":"140","author":"ER Dellacecca","year":"2020","unstructured":"Dellacecca ER, Cosgrove C, Mukhatayev Z et al (2020) Antibiotics drive microbial imbalance and vitiligo development in mice. J Invest Dermatol 140(3):676-687.e6","journal-title":"J Invest Dermatol"},{"issue":"2","key":"4162_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/1872214811666170301105101","volume":"10","author":"K Dhama","year":"2017","unstructured":"Dhama K, Sachan S, Khandia R et al (2017) Medicinal and beneficial health applications of Tinospora cordifolia (Guduchi): a miraculous herb countering various diseases\/disorders and its immunomodulatory effects. Recent Pat Endocr Metab Immune Drug Discov 10(2):96\u2013111. https:\/\/doi.org\/10.2174\/1872214811666170301105101","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"1","key":"4162_CR16","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/ijms24054910","volume":"24","author":"F Diotallevi","year":"2023","unstructured":"Diotallevi F, Gioacchini H, De Simoni E et al (2023) Vitiligo, from pathogenesis to therapeutic advances: State of the art. Int J Mol Sci 24(1):4910","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4162_CR17","volume":"14","author":"RR Dutta","year":"2022","unstructured":"Dutta RR, Kumar T, Ingole N (2022) Diet and vitiligo: the story so far. Cureus 14(8):e28516","journal-title":"Cureus"},{"issue":"6","key":"4162_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","volume":"22","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine K, Eleftheriadou V, Jones H et al (2021) Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol 22(6):757\u2013774","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"4162_CR19","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T et al (2012) Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 25(3):E1\u2013E13. https:\/\/doi.org\/10.1111\/j.1755-148X.2012.00997.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"4162_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","volume":"207","author":"S Faraj","year":"2022","unstructured":"Faraj S, Kemp EH, Gawkrodger DJ (2022) Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors. Clin Exp Immunol 207(1):27\u201343","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"4162_CR21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/abd1806-4841.20142717","volume":"89","author":"AR Faria","year":"2014","unstructured":"Faria AR, Mira MT, Tarl\u00e9 RG, de Castro CCS, Dellatorre G (2014) Vitiligo\u2014part 2\u2014classification, histopathology and treatment. An Bras Dermatol 89(5):784\u2013790","journal-title":"An Bras Dermatol"},{"key":"4162_CR22","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, Lu Y (2022) Advances in vitiligo: update on therapeutic targets. Front Immunol 13:986918","journal-title":"Front Immunol"},{"key":"4162_CR23","doi-asserted-by":"crossref","first-page":"18761","DOI":"10.1038\/srep18761","volume":"6","author":"P Ganju","year":"2016","unstructured":"Ganju P, Nagpal S, Mohammed MH et al (2016) Microbial community profiling shows dysbiosis in the lesional skin of vitiligo subjects. Sci Rep 6:18761","journal-title":"Sci Rep"},{"issue":"3","key":"4162_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0378-6323.62961","volume":"76","author":"BJ Garg","year":"2010","unstructured":"Garg BJ, Saraswat A, Bhatia A, Katare OP (2010) Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol 76(3):231","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"4162_CR25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/039463201402700403","volume":"27","author":"E Ghafouriani","year":"2014","unstructured":"Ghafouriani E, Ghafourian S, Sadeghifard N et al (2014) Vitiligo: Symptoms, pathogenesis and treatment. Int J Immunopathol Pharmacol 27(4):485\u2013489","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"4162_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3889\/oamjms.2018.048","volume":"6","author":"S Gianfaldoni","year":"2018","unstructured":"Gianfaldoni S, Wollina U, Tirant M, Tchernev G, Lotti J, Satolli F et al (2018) Herbal compounds for the treatment of vitiligo: a review. Open Access Maced J Med Sci 6(1):203","journal-title":"Open Access Maced J Med Sci"},{"issue":"11","key":"4162_CR27","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1111\/ijd.12779","volume":"54","author":"\u015e G\u00fcng\u00f6r","year":"2015","unstructured":"G\u00fcng\u00f6r \u015e, Nur\u00f6zler A, Akbay G, Ek\u015fio\u011flu M (2015) Tear functions in patients with vitiligo. Int J Dermatol 54(11):e466\u2013e468. https:\/\/doi.org\/10.1111\/ijd.12779","journal-title":"Int J Dermatol"},{"issue":"3","key":"4162_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5114\/pdia.2013.35619","volume":"30","author":"K Gutfreund","year":"2013","unstructured":"Gutfreund K, Bienias W, Szewczyk A, Kaszuba A (2013) Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol Alergol 30(3):165\u2013169. https:\/\/doi.org\/10.5114\/pdia.2013.35619","journal-title":"Postepy Dermatol Alergo"},{"issue":"21","key":"4162_CR29","doi-asserted-by":"crossref","first-page":"15654","DOI":"10.3390\/ijms242115654","volume":"24","author":"Z Han","year":"2023","unstructured":"Han Z, Min Y, Pang K, Wu D (2023) Therapeutic approach targeting gut microbiome in gastrointestinal infectious diseases. Int J Mol Sci 24(21):15654","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4162_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227909","volume":"15","author":"SW Henning","year":"2020","unstructured":"Henning SW, Jaishankar D, Barse LW et al (2020) The relationship between stress and vitiligo: evaluating perceived stress and electronic medical record data. PLoS ONE 15(1):e0227909","journal-title":"PLoS ONE"},{"issue":"7","key":"4162_CR31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines10071639","volume":"10","author":"N Hla\u010da","year":"2022","unstructured":"Hla\u010da N, \u017dagar T, Ka\u0161telan M, Brajac I, Prpi\u0107-Massari L (2022) Current concepts of vitiligo immunopathogenesis. Biomedicines 10(7):1639","journal-title":"Biomedicines"},{"issue":"1","key":"4162_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4162_CR33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0019-5154.57613","volume":"54","author":"A Jalel","year":"2009","unstructured":"Jalel A, Soumaya GS, Hamdaoui MH (2009) Vitiligo treatment with vitamins, minerals and polyphenol supplementation. Indian J Dermatol 54(4):357","journal-title":"Indian J Dermatol"},{"issue":"11","key":"4162_CR34","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","volume":"48","author":"Y Jin","year":"2016","unstructured":"Jin Y, Andersen G, Yorgov D et al (2016) Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 48(11):1418\u20131424","journal-title":"Nat Genet"},{"issue":"19","key":"4162_CR35","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.3390\/ijms241914632","volume":"24","author":"J Jaroslawska","year":"2023","unstructured":"Jaroslawska J, Carlberg C (2023) In vivo regulation of signal transduction pathways by vitamin D stabilizes homeostasis of human immune cells and counteracts molecular stress. Int J Mol Sci 24(19):14632","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4162_CR36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/ijdvl.IJDVL_313_18","volume":"85","author":"D Kamat","year":"2019","unstructured":"Kamat D, Prabhakaran N, Malathi M (2019) Follicular vitiligo: a rare presentation of vitiligo. Indian J Dermatol Venereol Leprol 85(4):414","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4162_CR37","volume":"12","author":"EL Katz","year":"2021","unstructured":"Katz EL, Harris JE (2021) Translational research in vitiligo. Front Immunol 12:624517","journal-title":"Front Immunol"},{"issue":"20","key":"4162_CR38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139342","volume":"5","author":"ML Kerns","year":"2020","unstructured":"Kerns ML, Miller RJ, Mazhar M et al (2020) Pathogenic and therapeutic role for NRF2 signaling in ultraviolet light\u2013induced skin pigmentation. JCI Insight 5(20):e139342","journal-title":"JCI Insight"},{"issue":"2","key":"4162_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/org.4.2.5851","volume":"4","author":"Y Komiya","year":"2008","unstructured":"Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4(2):68\u201375. https:\/\/doi.org\/10.4161\/org.4.2.5851","journal-title":"Organogenesis"},{"issue":"2","key":"4162_CR40","first-page":"1","volume":"22","author":"DE Kubelis-L\u00f3pez","year":"2021","unstructured":"Kubelis-L\u00f3pez DE, Zapata-Salazar NA, Said-Fern\u00e1ndez SL et al (2021) Updates and new medical treatments for vitiligo (Review). Exp Ther Med 22(2):1\u201311","journal-title":"Exp Ther Med"},{"issue":"11","key":"4162_CR41","first-page":"101","volume":"4","author":"DM Lakhani","year":"2014","unstructured":"Lakhani DM, Deshpande AS (2014) Various treatments for vitiligo: problems associated and solutions. J Appl Pharm Sci 4(11):101\u2013105.","journal-title":"J Appl Pharm"},{"key":"4162_CR42","doi-asserted-by":"crossref","first-page":"80959","DOI":"10.3389\/fphys.2014.00060","volume":"5","author":"MJ Larriba","year":"2014","unstructured":"Larriba MJ, Gonz\u00e1lez-Sancho JM, Bonilla F, Mu\u00f1oz A (2014) Interaction of vitamin D with membrane-based signaling pathways. Front Physiol 5:80959","journal-title":"Front Physiol"},{"key":"4162_CR43","doi-asserted-by":"crossref","first-page":"1291556","DOI":"10.3389\/fimmu.2024.1291556","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Zeng Y, Chen Z, Tan X, Mei X, Wu Z (2024) The role of aryl hydrocarbon receptor in vitiligo: a review. Front Immunol 15:1291556","journal-title":"Front Immunol"},{"issue":"3","key":"4162_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jdv.17815","volume":"36","author":"KH Lien","year":"2022","unstructured":"Lien KH, Ger TY, Chi CC (2022) Association of vitiligo with high-frequency sensorineural hearing loss: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 36(3):373\u2013379. https:\/\/doi.org\/10.1111\/jdv.17815","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4162_CR45","volume":"33","author":"Y Lin","year":"2024","unstructured":"Lin Y, Ding Y, Wu Y et al (2024) The underestimated role of mitochondria in vitiligo: from oxidative stress to inflammation and cell death. Exp Dermatol 33(1):e14856","journal-title":"Exp Dermatol"},{"issue":"1","key":"4162_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-023-03020-7","volume":"23","author":"M Luan","year":"2023","unstructured":"Luan M, Niu M, Yang P et al (2023) Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo. BMC Microbiol 23(1):1\u201311. https:\/\/doi.org\/10.1186\/s12866-023-03020-7","journal-title":"BMC Microbiol"},{"key":"4162_CR47","doi-asserted-by":"publisher","first-page":"1055958","DOI":"10.3389\/fimmu.2022.1055958","volume":"13","author":"C Lyu","year":"2022","unstructured":"Lyu C, Sun Y (2022) Immunometabolism in the pathogenesis of vitiligo. Front Immunol 13:1055958. https:\/\/doi.org\/10.3389\/fimmu.2022.1055958","journal-title":"Front Immunol"},{"issue":"1","key":"4162_CR48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.34297\/AJBSR.2021.12.001705","volume":"12","author":"SR Mansour","year":"2021","unstructured":"Mansour SR (2021) Microbial community of human skin and its role in vitiligo disease. Am J Biomed Sci Res 12(1):611\u2013616","journal-title":"Am J Biomed Sci Res"},{"issue":"4","key":"4162_CR49","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","volume":"97","author":"HZ Marchioro","year":"2022","unstructured":"Marchioro HZ, de Castro CCS, Fava VM et al (2022) Update on the pathogenesis of vitiligo. An Bras Dermatol 97(4):478","journal-title":"An Bras Dermatol"},{"issue":"5","key":"4162_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/der2.161","volume":"3","author":"N Mehta","year":"2022","unstructured":"Mehta N, Abdallah M, Gupta S (2022) Unravelling the paradox of reverse chronology in follicular vitiligo. Dermatol Rev 3(5):284\u2013288. https:\/\/doi.org\/10.1002\/der2.161","journal-title":"Dermatol Rev"},{"issue":"26","key":"4162_CR51","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood.2021013379","volume":"138","author":"AJ Moskowitz","year":"2021","unstructured":"Moskowitz AJ, Ghione P, Jacobsen E et al (2021) A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas. Blood 138(26):2828\u20132837. https:\/\/doi.org\/10.1182\/blood.2021013379","journal-title":"Blood"},{"issue":"1","key":"4162_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43045-021-00120-w","volume":"28","author":"MAEM Nasser","year":"2021","unstructured":"Nasser MAEM, El Tahlawi SMR, Abdelfatah ZA, Soltan MR (2021) Stress, anxiety, and depression in patients with vitiligo. Middle East Curr Psychiatry 28(1):1\u201310. https:\/\/doi.org\/10.1186\/s43045-021-00120-w","journal-title":"Middle East Curr Psychiatry"},{"issue":"1","key":"4162_CR53","first-page":"89","volume":"3","author":"K Naz","year":"2024","unstructured":"Naz K, Nawaz N (2024) Comparison of perceived stigmatization, social avoidance, and self-concept among male and female vitiligo patients. Lighthouse J Soc Sci 3(1):89\u2013102","journal-title":"Lighthouse J Soc Sci"},{"key":"4162_CR54","volume":"11","author":"Q Ni","year":"2020","unstructured":"Ni Q, Ye Z, Wang Y et al (2020) Gut microbial dysbiosis and plasma metabolic profile in individuals with vitiligo. Front Microbiol 11:592248","journal-title":"Front Microbiol"},{"issue":"1","key":"4162_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01369.x","volume":"20","author":"K Ongenae","year":"2006","unstructured":"Ongenae K, Beelaert L, van Geel N, Naeyaert JM (2006) Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 20(1):1\u20138. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01369.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4162_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41702-018-0030-y","volume":"2","author":"R Rahman","year":"2018","unstructured":"Rahman R, Hasija Y (2018) Exploring vitiligo susceptibility and management: a brief review. Biomed Dermatol 2(1):1\u201313. https:\/\/doi.org\/10.1186\/s41702-018-0030-y","journal-title":"Biomed Dermatol"},{"issue":"12","key":"4162_CR57","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/ijd.13761","volume":"56","author":"R Rekik","year":"2017","unstructured":"Rekik R, Ben Hmid A, Lajnef C et al (2017) Aryl hydrocarbon receptor (AhR) transcription is decreased in skin of vitiligo patients. Int J Dermatol 56(12):1509\u20131512. https:\/\/doi.org\/10.1111\/ijd.13761","journal-title":"Int J Dermatol"},{"key":"4162_CR58","unstructured":"(2024) Reversal and prevention of deregulated autophagy in cutaneous autoimmune disorders-a pilot study on vitiligo with nutrigenomics based approach of \u201cMaximum Nutrition and Minimum Medication. www.pigmentinternational.com"},{"issue":"2","key":"4162_CR59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","volume":"35","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M (2017) Skin cancer risk (nonmelanoma skin cancers\/melanoma) in vitiligo patients. Dermatol Clin 35(2):129\u2013134","journal-title":"Dermatol Clin"},{"issue":"11","key":"4162_CR60","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1111\/jocd.14429","volume":"20","author":"GR Rokni","year":"2021","unstructured":"Rokni GR, Gholami A, Kazeminejad A et al (2021) The relationship between stress and vitiligo during COVID-19 pandemic. J Cosmet Dermatol 20(11):3387","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"4162_CR61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3892\/etm.2021.9743","volume":"21","author":"S Said Fernandez","year":"2021","unstructured":"Said Fernandez S, Sanchez Dom\u00ednguez C, Salinas Santander M et al (2021) Novel immunological and genetic factors associated with vitiligo: a review. Exp Ther Med 21(4):312","journal-title":"Exp Ther Med"},{"issue":"3","key":"4162_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","volume":"73","author":"VN Sehgal","year":"2007","unstructured":"Sehgal VN, Srivastava G (2007) Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol 73(3):149","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"4162_CR63","first-page":"7","volume":"29","author":"LB Sel\u00e7uk","year":"2020","unstructured":"Sel\u00e7uk LB, Katkat E, Ar\u0131ca DA, Yayl\u0131 S, Bahad\u0131r S (2020) Sun-protection habits and knowledge of patients with vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 29(1):7\u201310","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"4162_CR64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711080","volume":"12","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K (2021) Editorial: immunology of vitiligo. Front Immunol 12:711080","journal-title":"Front Immunol"},{"key":"4162_CR65","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2016.00003","volume":"7","author":"C Shen","year":"2016","unstructured":"Shen C, Gao J, Sheng Y et al (2016) Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front Genet 7:168861","journal-title":"Front Genet"},{"issue":"9","key":"4162_CR66","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.medcli.2019.09.022","volume":"154","author":"JTD Souto Filho","year":"2020","unstructured":"Souto Filho JTD, Beiral ES, Azevedo FS, Gon\u00e7alves JGRRS, Kohler LIA, Guimar\u00e3es SS (2020) Predictive risk factors for autoimmune thyroid diseases in patients with pernicious anemia. Med Clin (Barc) 154(9):344\u2013347","journal-title":"Med Clin (Barc)"},{"issue":"17","key":"4162_CR67","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/jcm13175225","volume":"13","author":"R Speeckaert","year":"2024","unstructured":"Speeckaert R, Van Caelenberg E, Belpaire A, Speeckaert MM, Van Geel N (2024) Vitiligo: from pathogenesis to treatment. J Clin Med 13(17):5225","journal-title":"J Clin Med"},{"issue":"2","key":"4162_CR68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","volume":"35","author":"RA Spritz","year":"2017","unstructured":"Spritz RA, Andersen GHL (2017) Genetics of vitiligo. Dermatol Clin 35(2):245","journal-title":"Dermatol Clin"},{"issue":"1","key":"4162_CR69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2005.10.001","volume":"41","author":"RA Spritz","year":"2006","unstructured":"Spritz RA (2006) The genetics of generalized vitiligo and associated autoimmune diseases. J Dermatol Sci 41(1):3\u201310","journal-title":"J Dermatol Sci"},{"issue":"3","key":"4162_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2567.2009.03054.x","volume":"127","author":"EA Stevens","year":"2009","unstructured":"Stevens EA, Mezrich JD, Bradfield CA (2009) The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127(3):299\u2013311. https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03054.x","journal-title":"Immunology"},{"issue":"6","key":"4162_CR71","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1192\/bjo.2022.591","volume":"8","author":"AR Thompson","year":"2022","unstructured":"Thompson AR, Eleftheriadou V, Nesnas J (2022) The mental health associations of vitiligo: UK population-based cohort study. BJPsych Open 8(6):e190","journal-title":"BJPsych Open"},{"issue":"8","key":"4162_CR72","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/labinvest.3780318","volume":"81","author":"R Van den Wijngaard","year":"2001","unstructured":"Van den Wijngaard R, Wankowicz-Kalinska A, Pals S, Weening J, Das P (2001) Autoimmune melanocyte destruction in vitiligo. Lab Invest 81(8):1061\u20131067","journal-title":"Lab Invest"},{"issue":"1","key":"4162_CR73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.18231\/j.ijced.2022.008","volume":"8","author":"K Varma","year":"2022","unstructured":"Varma K, Kumar U, Mahadik A, Jat Y (2022) An observational study of vitiligo. IP Indian J Clin Exp Dermatol 8(1):39\u201342","journal-title":"IP Indian J Clin Exp Dermatol"},{"issue":"1","key":"4162_CR74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J et al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110\u2013119","journal-title":"Am J Gastroenterol"},{"key":"4162_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754175","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Luo L, Ding Q, Wu Z, Peng Y, Li J et al (2021) Development of a multi-target strategy for the treatment of vitiligo via machine learning and network analysis methods. Front Pharmacol 12:754175. https:\/\/doi.org\/10.3389\/fphar.2021.754175","journal-title":"Front Pharmacol"},{"key":"4162_CR76","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1038\/srep13542","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang X, Li K, Liu L et al (2015) AHR promoter variant modulates its transcription and downstream effectors by allele-specific AHR-SP1 interaction functioning as a genetic marker for vitiligo. Sci Rep 5:13542","journal-title":"Sci Rep"},{"issue":"5","key":"4162_CR77","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-2133.2011.10798.x","volume":"166","author":"XW Wang","year":"2012","unstructured":"Wang XW, Li K, Guo S et al (2012) The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations. Br J Dermatol 166(5):1081\u20131087. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10798.x","journal-title":"Br J Dermatol"},{"issue":"7891","key":"4162_CR78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen D, Hu Y et al (2022) Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature 601(7891):118\u2013124. https:\/\/doi.org\/10.1038\/s41586-021-04221-8","journal-title":"Nature"},{"issue":"6","key":"4162_CR79","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.7150\/thno.30398","volume":"9","author":"X Yi","year":"2019","unstructured":"Yi X, Guo W, Shi Q et al (2019) SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo. Theranostics 9(6):1614\u20131633","journal-title":"Theranostics"},{"key":"4162_CR80","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2147\/CCID.S453259","volume":"17","author":"L Zhao","year":"2024","unstructured":"Zhao L, Hu M, Li L (2024) Identifying the genetic associations between diabetes mellitus and the risk of vitiligo. Clin Cosmet Investig Dermatol 17:2261\u20132271. https:\/\/doi.org\/10.2147\/CCID.S453259","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04162-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:38:03Z","timestamp":1744141083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04162-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4162"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04162-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"685"}}